Literature DB >> 18477505

Synthesis and antiproliferative activity of imidazole and imidazoline analogs for melanoma.

Jianjun Chen1, Zhao Wang, Yan Lu, James T Dalton, Duane D Miller, Wei Li.   

Abstract

We have previously reported substituted 2-aryl-thiazolidine-4-carboxylic acid amides as potent and selective antiproliferative agents for melanoma. To understand the importance of the thiazolidine ring and to reduce potential complications associated with the two chiral centers, we designed and synthesized sets of new analogs by modifying this ring. These new analogs were tested in two melanoma cell lines and fibroblast cells (negative controls). Compared with the older analogs containing the thiazolidine ring, these new analogs have lower potency in general, but some of these analogs still have very good selectivity. These structure-activity studies indicated that the thiazolidine ring is very critical for the activity for these series of compounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477505      PMCID: PMC2494854          DOI: 10.1016/j.bmcl.2008.04.073

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  23 in total

Review 1.  Chemotherapy for metastatic melanoma.

Authors:  Marta Mandarà; Rolando Nortilli; Teodoro Sava; Gian Luigi Cetto
Journal:  Expert Rev Anticancer Ther       Date:  2006-01       Impact factor: 4.512

Review 2.  Chemotherapy for metastatic melanoma: time for a change?

Authors:  Helen J Gogas; John M Kirkwood; Vernon K Sondak
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

3.  Synthesis and identification of small molecules that potently induce apoptosis in melanoma cells through G1 cell cycle arrest.

Authors:  Robin S Dothager; Karson S Putt; Brittany J Allen; Benjamin J Leslie; Vitaliy Nesterenko; Paul J Hergenrother
Journal:  J Am Chem Soc       Date:  2005-06-22       Impact factor: 15.419

Review 4.  Treatment of metastatic malignant melanoma.

Authors:  Ehab Atallah; Lawrence Flaherty
Journal:  Curr Treat Options Oncol       Date:  2005-05

5.  Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer.

Authors:  Veeresa Gududuru; Eunju Hurh; James T Dalton; Duane D Miller
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

Review 6.  Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance.

Authors:  Henry B Koon; Michael B Atkins
Journal:  Expert Rev Anticancer Ther       Date:  2007-01       Impact factor: 4.512

7.  Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.

Authors:  L Serrone; M Zeuli; F M Sega; F Cognetti
Journal:  J Exp Clin Cancer Res       Date:  2000-03

Review 8.  Diagnosis and treatment of cutaneous melanoma: state of the art 2006.

Authors:  Claus Garbe; Thomas K Eigentler
Journal:  Melanoma Res       Date:  2007-04       Impact factor: 3.599

9.  A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.

Authors:  J M G Larkin; S A Hughes; D A Beirne; P M Patel; I M Gibbens; S C Bate; K Thomas; T G Eisen; M E Gore
Journal:  Br J Cancer       Date:  2006-12-05       Impact factor: 7.640

10.  Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.

Authors:  T Eisen; T Ahmad; K T Flaherty; M Gore; S Kaye; R Marais; I Gibbens; S Hackett; M James; L M Schuchter; K L Nathanson; C Xia; R Simantov; B Schwartz; M Poulin-Costello; P J O'Dwyer; M J Ratain
Journal:  Br J Cancer       Date:  2006-08-01       Impact factor: 7.640

View more
  9 in total

1.  Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents.

Authors:  Jianjun Chen; Zhao Wang; Chien-Ming Li; Yan Lu; Pavan K Vaddady; Bernd Meibohm; James T Dalton; Duane D Miller; Wei Li
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

2.  New substituted 4H-chromenes as anticancer agents.

Authors:  Shivaputra A Patil; Jin Wang; Xiaochen S Li; Jianjun Chen; Terreia S Jones; Amira Hosni-Ahmed; Renukadevi Patil; William L Seibel; Wei Li; Duane D Miller
Journal:  Bioorg Med Chem Lett       Date:  2012-04-24       Impact factor: 2.823

3.  Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents.

Authors:  Jianjun Chen; Sunjoo Ahn; Jin Wang; Yan Lu; James T Dalton; Duane D Miller; Wei Li
Journal:  J Med Chem       Date:  2012-08-06       Impact factor: 7.446

4.  Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization.

Authors:  Jianjun Chen; Chien-Ming Li; Jin Wang; Sunjoo Ahn; Zhao Wang; Yan Lu; James T Dalton; Duane D Miller; Wei Li
Journal:  Bioorg Med Chem       Date:  2011-07-01       Impact factor: 3.641

5.  Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.

Authors:  Bernard L Flynn; Gurmit S Gill; Damian W Grobelny; Jason H Chaplin; Dharam Paul; Annabell F Leske; Tina C Lavranos; David K Chalmers; Susan A Charman; Edmund Kostewicz; David M Shackleford; Julia Morizzi; Ernest Hamel; M Katherine Jung; Gabriel Kremmidiotis
Journal:  J Med Chem       Date:  2011-08-05       Impact factor: 7.446

Review 6.  Imidazoles as potential anticancer agents.

Authors:  Imran Ali; Mohammad Nadeem Lone; Haasan Y Aboul-Enein
Journal:  Medchemcomm       Date:  2017-04-13       Impact factor: 3.597

7.  Parkia speciosa Hassk.: A Potential Phytomedicine.

Authors:  Yusof Kamisah; Faizah Othman; Hj Mohd Saad Qodriyah; Kamsiah Jaarin
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-17       Impact factor: 2.629

8.  Influence of Steric Effect on the Pseudo-Multicomponent Synthesis of N-Aroylmethyl-4-Arylimidazoles.

Authors:  Nerith Rocio Elejalde-Cadena; Mayra García-Olave; David Figueroa; Pietro Vidossich; Gian Pietro Miscione; Jaime Portilla
Journal:  Molecules       Date:  2022-02-09       Impact factor: 4.411

9.  Imidazole as a Promising Medicinal Scaffold: Current Status and Future Direction.

Authors:  Sahar S Alghamdi; Rasha S Suliman; Khlood Almutairi; Khawla Kahtani; Dimah Aljatli
Journal:  Drug Des Devel Ther       Date:  2021-07-29       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.